EPSRC IAA Project weDecide: Clinical Tool for Shared Decision-Making for Treatment of Menopause Symptoms

EPSRC IAA Project weDecide: Clinical Tool for Shared Decision-Making for Treatment of Menopause Symptoms (Jan 2024 – Jan 2025)

10 per cent of women leave the workforce due to menopause, while one in four considers leaving. The weDecide project aims to evaluate a novel technique to support personalised and shared decision-making (PSDM) for menopause treatment that considers not just the criteria of a menopause expert but also that of the woman experiencing the peri-menopausal symptoms. The technique builds on the decision-making AI-based tool developed in the EPSRC project Twenty20Insight, which considers the priorities/preferences of humans. weDecide focuses on assessing the clinical relevance and acceptability of the decisions prompted by the weDecide Tool, and will inform an EPSRC bid.

People:

• Dr Nelly Bencomo (PI)
• Prof Dorothy Monekoso (co-PI)
• Dr Huma Sami (PDRA)
• Dr Jennifer Horrocks – MBBS, PGCertClinEd, MRCGP GP and
• Menopause Specialist, BAY MEDICAL GROUP

weDecide Tool

The following are images of the current version of the prototype of the weDecide Tool we are developing. The status of the prototype will be updated here as we make progress. Last update 2024-08-21.

Menopause Symptoms and Treatment Preferences

Treatment Recommendations

Patient Symptoms

Patient History